Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung
- 31 May 1989
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (5) , 909-910
- https://doi.org/10.1016/0277-5379(89)90140-5
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Drug Dependent Red Cell Antibodies and Intravascular Haemolysis Occurring in Patients Treated with 9 Hydroxy‐Methyl‐EllipticiniumBritish Journal of Haematology, 1980
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancersPublished by Elsevier ,1978
- Synthesis of the tumour-inhibitory alkaloids, ellipticine, 9-methoxyellipticine, and related pyrido[4,3-b]carbazolesAustralian Journal of Chemistry, 1967